Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Rusakova (Moscow, Russian Federation), S. Saenko (Moscow, Russian Federation), S. Sterlikov (Moscow, Russian Federation). Predictors of death in patients with MDR-TB and HIV. 1599

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017 Lymphopenia as a mortality predictor in non HIV pulmonary TB patients Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 The death analysis of HIV-infected patients in the antituberculous hospital Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 Impact of seasons on tuberculosis mortality for HIV+ and HIV- TB patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Untimely found TB cases and causes of death among patients infected with HIV/TB and with TB alone in the Leningrad region Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection Source: ISSN=ISSN 1810-6838, ISBN=, page=190 Year: 2006 Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Problems in reporting cause of death in patients with tuberculosis (TB) Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Hospitalized tuberculosis: HIV versus non-HIV patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017 Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Features of TB/HIV co-infection and treatment outcome Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Immunologic recovery in HIV/TB co-infected patients after anti-TB treatment Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019